Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24521741)

1.

Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.

Liu AY, Liu DG, Du YJ, Pei FH, Yang G, Liu BR, Zhang HT, Wang XH, Fan YJ, Chen YZ, Jiang Y, Chen J.

Cancer Biol Ther. 2014 May;15(5):489-95. doi: 10.4161/cbt.28016. Epub 2014 Feb 12.

2.

Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.

Cui G, Qi H, Gundersen MD, Yang H, Christiansen I, Sørbye SW, Goll R, Florholmen J.

Cancer Immunol Immunother. 2015 Feb;64(2):181-90. doi: 10.1007/s00262-014-1624-x. Epub 2014 Oct 17.

PMID:
25324197
3.

Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.

Alqurashi N, Gopalan V, Smith RA, Lam AK.

Hum Pathol. 2013 Oct;44(10):2089-96. doi: 10.1016/j.humpath.2013.03.014. Epub 2013 Jun 14.

PMID:
23773481
4.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
5.

The roles of JK-1 (FAM134B) expressions in colorectal cancer.

Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.

Exp Cell Res. 2014 Aug 1;326(1):166-73. doi: 10.1016/j.yexcr.2014.06.013. Epub 2014 Jun 25.

PMID:
24973512
6.

Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.

Luo B, Yun X, Fan R, Lin YD, He SJ, Zhang QM, Mo FR, Chen F, Xiao SW, Xie XX.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2835-45. eCollection 2013.

7.

Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.

Celesti G, Di Caro G, Bianchi P, Grizzi F, Basso G, Marchesi F, Doni A, Marra G, Roncalli M, Mantovani A, Malesci A, Laghi L.

Gastroenterology. 2013 Sep;145(3):647-57.e15. doi: 10.1053/j.gastro.2013.05.011. Epub 2013 May 15.

PMID:
23684708
8.

Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.

Hosono K, Yamada E, Endo H, Takahashi H, Inamori M, Hippo Y, Nakagama H, Nakajima A.

World J Gastroenterol. 2012 Oct 14;18(38):5360-8. doi: 10.3748/wjg.v18.i38.5360.

9.

Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.

Peng L, Tu P, Wang X, Shi S, Zhou X, Wang J.

J Mol Histol. 2014 Oct;45(5):555-63. doi: 10.1007/s10735-014-9577-0. Epub 2014 Jun 5.

PMID:
24912672
10.

NPRL2 gene expression in the progression of colon tumors.

Yogurtcu B, Hatemi I, Aydin I, Buyru N.

Genet Mol Res. 2012 Sep 12;11(4):4810-6. doi: 10.4238/2012.September.12.3.

PMID:
23079973
11.

Expression of hippo pathway in colorectal cancer.

Liang K, Zhou G, Zhang Q, Li J, Zhang C.

Saudi J Gastroenterol. 2014 May-Jun;20(3):188-94. doi: 10.4103/1319-3767.133025.

12.

Tissue and serum galectin-1 expression in patients with colorectal carcinoma.

Sheng TH, Rong LX, Li ZY, Bo J, Lei S.

Hepatogastroenterology. 2012 Mar-Apr;59(114):389-94. doi: 10.5754/hge09232.

PMID:
22353504
13.
14.
15.

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.

Lorentzen A, Vogel LK, Lewinsky RH, Saebø M, Skjelbred CF, Godiksen S, Hoff G, Tveit KM, Lothe IM, Ikdahl T, Kure EH, Mitchelmore C.

BMC Cancer. 2007 Oct 12;7:192.

16.

IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.

Cui G, Yuan A, Goll R, Florholmen J.

Scand J Gastroenterol. 2012 Nov;47(11):1304-12. doi: 10.3109/00365521.2012.725089. Epub 2012 Sep 19.

PMID:
22989213
17.

Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.

Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, Wang H, Chen XW, Xiao HQ, Li YY.

World J Gastroenterol. 2007 Feb 21;13(7):1018-26.

18.

Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.

Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F, Yuan YZ.

Int J Oncol. 2009 Mar;34(3):821-8.

PMID:
19212687
19.

High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.

Zheng L, Xie G, Duan G, Yan X, Li Q.

PLoS One. 2011;6(7):e22203. doi: 10.1371/journal.pone.0022203. Epub 2011 Jul 12.

20.

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.

Vogel LK, Saebø M, Skjelbred CF, Abell K, Pedersen ED, Vogel U, Kure EH.

BMC Cancer. 2006 Jul 4;6:176.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk